MIF and acute myeloid leukemia: Delving deeper into the mechanisms of non-remission post-chemotherapy, our differential analysis revealed that specific pathways, including CCL, IFN-II, GALECTIN, and MIF, witness heightened expression in non-remission acute myeloid leukemia after chemotherapy (Fig. 5E).